The Severity of SARS-CoV-2 Infection among Patients with Multiple Sclerosis

The Severity of SARS-CoV-2 Infection among Patients with Multiple Sclerosis

Background: Neurological disability associated with multiple sclerosis and immunosuppressive or immunomodulatory therapy which is administered for it may increase the risk of SARS-CoV-2 infection and its morbidity/mortality.In this study, we evaluated the severity of SARS-CoV-2 infection in patients...

Full description

Bibliographic Details
Main Authors: Mahnaz Bayat, Alireza Fayyazpoor, Afshin Borhani Haghighi, Daniyal Salehi, Hossein Molavi Vardanjan, Maryam Poursadeghfard
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2021-11-01
Series:Journal of Kerman University of Medical Sciences
Subjects:
covid-19
immunosuppressive
multiple sclerosis
general population
immunomodulatory therapy
Online Access:https://jkmu.kmu.ac.ir/article_91832_da620991d1a0aea5cbab817bf20bddf5.pdf

Internet

https://jkmu.kmu.ac.ir/article_91832_da620991d1a0aea5cbab817bf20bddf5.pdf

Similar Items